Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday. The AIM-traded firm said the tax credit pertained to the financial year ended 31 March 2023, and was attributed to its efforts in advancing and refining the 'OptiMAL' platform, along with other endeavours in bioinformatics, antigen design, and cell culture.

It said the awarded tax credit met its expectations, amounting to almost £0.28m.

"The research and development tax credit system is of enormous benefit to companies developing cutting edge technologies such as we continue to do at Fusion," said chief executive officer Adrian Kinkaid.

"We are now beginning to reap the benefits of the resultant technology platforms with an elevated profile in our field and anticipate considerable commercial growth to be generated from them in the coming years."

At 1543 GMT, shares in Fusion Antibodies were up 1.05% at 4.8p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Frontier IP's Alusid launches another range with Topps Tiles
(Sharecast News) - Frontier IP announced on Friday that its portfolio company Alusid has launched its first range of floor tiles through Parkside Architectural Tiles, the commercial division of Topps Tiles.
Enteq appoints new head of finance
(Sharecast News) - Energy service engineering and technology company Enteq announced the appointment of Amir Absoud as its head of finance on Friday, to immediately succeed the current chief financial officer, Mark Ritchie.
EnSilica to raise £0.3m through retail offer
(Sharecast News) - EnSilica announced a retail offer through the Winterflood Retail Access Platform (WRAP) on Friday, to raise up to £0.3m.
Recurring revenue, adjusted earnings rise for Pulsar Group
(Sharecast News) - Audience intelligence software specialist Pulsar Group said in its final results on Friday that its annualised recurring revenue (ARR) increased £2.7m, a significant improvement from the flat performance in the prior financial year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.